close

NASDAQ: AGRX Agile Therapeutics Anticipates Increased Growth In Q3 of 2022

Contact Details

Matt Riley - Head of Investor Relations & Corporate Communications

mriley@agiletherapeutics.com

Company Website

https://agiletherapeutics.com/

More News

View More

Recent Quotes

View More
Symbol Price Change (%)
AMZN  205.27
+0.00 (0.00%)
AAPL  266.18
+0.00 (0.00%)
AMD  196.60
+0.00 (0.00%)
BAC  51.07
+0.00 (0.00%)
GOOG  311.69
+0.00 (0.00%)
META  637.46
+0.21 (0.03%)
MSFT  384.47
+0.00 (0.00%)
NVDA  191.55
+0.00 (0.00%)
ORCL  141.31
+0.00 (0.00%)
TSLA  399.83
+0.00 (0.00%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Starting at $3.75/week.

Subscribe Today